Vaping cessation pill under trial: varenicline tested on 326 adults

NCT ID NCT07040566

Recruiting now Disease control Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 33 times

Summary

This study tests whether the medication varenicline can help adults quit using e-cigarettes. Researchers will compare varenicline to a placebo in 326 people who vape daily. The main goal is to see if more participants can stop vaping for at least a week by the 12-week mark, with a follow-up at 26 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NICOTINE DEPENDENCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Hollings Cancer Center at MUSC (HCC)
RECRUITING

Charleston, South Carolina, 29425, United States
Yale Cancer Center/Smilow Cancer Hospital at Yale-New Haven
RECRUITING

New Haven, Connecticut, 06520, United States

Conditions

The condition(s) this trial relates to.

nicotine dependence Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

E CIGARETTE USE E-CIGARETTE USE NICOTINE DEPENDENCE VAPING VAPING